Urogenital tuberculosis — epidemiology, pathogenesis and clinical features
interstitial pneumonia :: Article Creator Therapeutic Protein Offers New Hope For Inflammatory Lung Diseases Register for free to listen to this article Thank you. Listen to this article using the player above. ✖ Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases (ILDs), a family of conditions that all involve some level of inflammation and fibrosis, or scarring, of the lungs. In the U.S., pulmonary sarcoidosis affects around 200,000 patients. The cause is unknown, and no new treatments have been introduced in the past 70 years. In a paper published in Science Translational Medicine on March 12, 2025, scientists at Scripps Research and aTyr Pharma characterized a protein, HARSWHEP, that can soothe the inflammation associated with sarcoidosis by regulating white blood cells. Reducing inflam...